Rhythm Pharmaceuticals' potential first-in-class HO drug, strong pipeline, and limited competition offer blockbuster potential. Click to read why RYTM is a Buy.

The number of performing rights organizations has proliferated in recent years, leaving some venues struggling to pay fees ...

Stratifying body mass index (BMI) categories by waist circumference (WC) thresholds improves mortality risk prediction in ...

Shares of Rhythm Pharmaceuticals RYTM were up 36.6% yesterday after it reported positive top-line data from a phase II study ...

Know your heart disease risk. It’s smart to have your heart risk assessed and “know your numbers” (BMI, blood pressure, blood sugar, cholesterol). If you’re obese, be watchful for signs of heart ...

Prenatal and early-life factors significantly influence childhood obesity trajectories, highlighting the need for early ...

HealthDay News — The European Association for the Study of Obesity (EASO) framework may offer a more sensitive measure of obesity than traditional body mass index (BMI), according to a study published ...

New data from The Ohio State University Wexner Medical Center Comprehensive Transplant Center shows obese patients with end stage kidney disease and diabetes can safely use weight loss injections to ...

Rhythm's bivamelagon cut BMI and hunger scores in Phase 2 trial for hypothalamic obesity, prompting plans to discuss Phase 3 ...